PharmaCann Archives - Cannabis Business Executive - Cannabis and Marijuana industry news

MSOs Make the Case for Immediate Inclusion in NY’s Adult-Use Market

March 16, 2023
Tom Hymes
Compliance and Regulations, News & Insights
0 Comments

UPDATED In a report prepared by MPG Consulting on behalf of Acreage Holdings titled New York Illicit Cannabis Market Absorption Analysis, the multistate operator presents a series of arguments and accompanying scenarios that depict varying outcomes for success with respect…

John Lord: LivWell Will Remain LivWell Following PharmaCann Merger/Acquisition

November 1, 2021
Tom Hymes
Mergers & Acquisitions, Multiple State Operators, Spotlight
1 Comment

Founded in 2009, Colorado-based multistate operator LivWell Enlightened Health has over the years established itself as one of the industry’s more proficient players by utilizing the skills and grit that its Kiwi founder and longtime Colorado resident John Lord brought…

Healthcare & Pharmaceuticals U.S. cannabis firm PharmaCann plans IPO as New York weed legalization lifts demand -sources

Aug 16 (Reuters) - PharmaCann, one of the 10 original cannabis licensees in New York, has confidentially filed for an initial public offering that could value it at well over $1 billion, sources familiar with the matter told Reuters. The…

Here’s how millennials and boomers differ on marijuana use

Baby boomers and millennials can’t agree on anything: the economy, social values, and smoking cannabis. Not whether or not they should consume the plant — boomers now smoke more cannabis than high schoolers — but how, when and where and…

Chicago-based Grassroots Cannabis sold in $830 million deal

An $830 million deal to acquire Grassroots Cannabis closed Thursday, upending a trend of failed multimillion-dollar acquisitions of Chicago-based marijuana companies. Grassroots, which has a cultivation facility in Litchfield and is affiliated with eight dispensaries around the state, was acquired…

One of the biggest deals in the cannabis industry just fell apart. What the MedMen-PharmaCann breakup means for marijuana in Illinois.

When MedMen Enterprises agreed to buy Chicago-based PharmaCann last year, the $682 million deal was one of the biggest in the history of the legal marijuana industry. Now, it’s one of the biggest to fall apart. On Tuesday, the companies announced they…

MedMen Plunges After Scrapping PharmaCann Merger; Marijuana Stocks Slide

California-based marijuana retailer MedMen (OTC:MMNFF) on Tuesday said it would terminate its merger with PharmaCann and appointed a new CFO, killing off a deal that would have made it one of the biggest cannabis companies in the U.S. MedMen stock…